For the most part, ACSL4 expression is upregulated in cancer when compared with normal tissue, as is observed in the instances of colorectal cancer [21, 29], hepatocellular carcinoma [30–32] and multiple myeloma [33] and has been demonstrated to mediate increases in proliferation, migration and invasion in these cancers. The gene discussed is ACSL4; the disease is plasma cell myeloma.